Genomics and perinatal care

New England Journal of Medicine

Volumn 366, Issue 1, 2012, Pages 64-73

  Bodurtha, Joann ^a   Strauss III, Jerome F ^b  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA N ACETYLHEXOSAMINIDASE; DNA FRAGMENT; MITOCHONDRIAL DNA; PROTEIN;

ALLELE; AMNIOCENTESIS; BETA THALASSEMIA; BIOINFORMATICS; BLASTOCYST; BLASTOMERE; CHILD HEALTH; CHORION VILLUS; CHROMOSOME; COPY NUMBER VARIATION; COST; CYSTIC FIBROSIS; CYTOGENETICS; DMD GENE; DMPK GENE; DNA HYBRIDIZATION; DNA SEQUENCE; DUCHENNE MUSCULAR DYSTROPHY; ENDOCRINE DISEASE; FETUS CELL; FLUORESCENCE IN SITU HYBRIDIZATION; FMR1 GENE; FRAGILE X SYNDROME; GENE PRODUCT; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC DISORDER; GENETIC RISK; GENETIC SCREENING; GENETIC VARIABILITY; GENOMICS; HBB GENE; HEMOGLOBINOPATHY; HEMOPHILIA; HEREDITARY MOTOR SENSORY NEUROPATHY; HTT GENE; HUMAN; HUNTINGTON CHOREA; INFERTILITY THERAPY; INFORMED CONSENT; MATERNAL CARE; MATERNAL WELFARE; METABOLIC DISORDER; MUTATIONAL ANALYSIS; MYOTONIC DYSTROPHY; NEWBORN SCREENING; NON INVASIVE PROCEDURE; PERINATAL CARE; PHENYLKETONURIA; PMP22 GENE; POLYMERASE CHAIN REACTION; PRACTICE GUIDELINE; PREIMPLANTATION EMBRYO; PRIORITY JOURNAL; REVIEW; SENSITIVITY AND SPECIFICITY; SICKLE CELL ANEMIA; SINGLE NUCLEOTIDE POLYMORPHISM; SPINAL MUSCULAR ATROPHY; X CHROMOSOME LINKED DISORDER; ZNF9 GENE; METHODOLOGY; NEWBORN; PRENATAL CARE; PRENATAL DIAGNOSIS;

GENETIC DISEASES, INBORN; GENETIC TESTING; GENOMICS; HUMANS; INFANT, NEWBORN; NEONATAL SCREENING; PERINATAL CARE; PRECONCEPTION CARE; PREIMPLANTATION DIAGNOSIS; PRENATAL CARE;

EID: 84855744285     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMra1105043     Document Type: Review

References (62)

1. American College of Obstetricians and Gynecologists Committee on Genetics. Committee opinion no. 478: family history as a risk assessment tool. Obstet Gynecol 2011;117:747-50.
2. Genetic services policy project final report. Seattle: Washington State Department of Health, 2008 (http://depts.washington .edu/genpol/docs/ FinalReport.pdf).
3. Sharp RR, Goldlust ME, Eng C. Addressing gaps in physician education using personal genomic testing. Genet Med 2011; 13:750-1.
4. de Jong A, Dondorp WJ, Frints SGM, de Die-Smulders CEM, de Wert GMWR. Advances in prenatal screening: the ethical dimension. Nat Rev Genet 2011;12: 657-63.
5. American College of Obstetricians and Gynecologists Committee on Genetics. ACOG practice bulletin no. 77: screening for fetal chromosomal abnormalities. Obstet Gynecol 2007;109:217-27.
6. Idem. ACOG practice bulletin no. 486: update on carrier screening for cystic fibrosis. Obstet Gynecol 2011;117:1028-31.
7. Idem. ACOG committee opinion no. 338: screening for fragile X syndrome. Obstet Gynecol 2006;107:1483-5.
8. Idem. ACOG practice bulletin no. 78: hemoglobinopathies in pregnancy. Obstet Gynecol 2007;109:229-37.
9. Idem. ACOG committee opinion no. 442: preconception and prenatal carrier screening for genetic diseases in individuals of Eastern European Jewish descent. Obstet Gynecol 2009;114:950-3.
10. Idem. ACOG committee opinion no. 432: spinal muscular atrophy. Obstet Gynecol 2009;113:1194-6.
11. Driscoll DA, Gross SJ. Screening for fetal aneuploidy and neural tube defects. Genet Med 2009;11:818-21.
12. Grody WW, Cutting GR, Klinger KW, Richards CS, Watson MS, Desnick RJ. Laboratory standards and guidelines forpopulation-based cystic fibrosis carrier screening. Genet Med 2001;3:149-54.
13. Watson MS, Cutting GR, Desnick RJ, et al. Cystic fibrosis population carrier screening: 2004 revision of American College of Medical Genetics mutation panel. Genet Med 2004;6:387-91. [Errata, Genet Med 2004;6:548, 2005;7:286.] (Pubitemid 39310514)
14. Sherman S, Pletcher BA, Driscoll DA. Fragile X syndrome: diagnostic and carrier testing. Genet Med 2005;7:584-7. (Pubitemid 41566485)
15. Gross SJ, Pletcher BA, Monaghan KG. Carrier screening in individuals of Ashkenazi Jewish descent. Genet Med 2008;10: 54-6.
16. Prior TW. Carrier screening for spinal muscular atrophy. Genet Med 2008;10: 840-2.
17. Bell CJ, Dinwiddie DL, Miller NA, et al. Carrier testing for severe childhood recessive diseases by next-generation sequencing. Sci Transl Med 2011;3:65ra4.
18. Kaback MM, Desnick RJ. Hexosaminidase A deficiency. In: Pagon RA, Bird TD, Dolan CR, Stephens K, eds. GeneReviews. Seattle: University of Washington, 1993-1999 (updated Aug. 11, 2011) (http://www .ncbi.nlm.nih.gov/books/NBK1218).
19. Anderson RA, Pickering S. The current status of preimplantation genetic screening: British Fertility Society policy and practice guidelines. Hum Fertil (Camb) 2008;11:71-5. (Pubitemid 351935233)
20. Munné S, Howles CM, Wells D. The role of preimplantation genetic diagnosis in diagnosing embryo aneuploidy. Curr Opin Obstet Gynecol 2009;21:442-9.
21. Cooper AR, Jungheim ES. Preimplantation genetic testing: indications and controversies. Clin Lab Med 2010;30:519-31.
22. Mastenbroek S, Twisk M, van der Veen F, Repping S. Preimplantation genetic screening: a systematic review and meta-analysis of RCTs. Hum Reprod Update 2011;17:454-66.
23. Treff NR, Levy B, Su J, Northrop LE, Tao X, Scott RT Jr. SNP microarray-based 24 chromosome aneuploidy screening is significantly more consistent than FISH. Mol Hum Reprod 2010;16:583-9.
24. Spits C, Sermon K. PGD for monogenic disorders: aspects of molecular biology. Prenat Diagn 2009;29:50-6.
25. Alfarawati S, Fragouli E, Colls P, Wells D. First births after preimplantation genetic diagnosis of structural chromosome abnormalities using comparative genomic hybridization and microarray analysis. Hum Reprod 2011;26:1560-74.
26. Bredenoord A, Dondorp W, Pennings G, de Die-Smulders C, Smeets B, de Wert G. Preimplantation genetic diagnosis for mitochondrial DNA disorders: ethical guidance for clinical practice. Eur J Hum Genet 2009;17:1550-9.
27. Kuliev A, Rechitsky S. Polar body based preimplantation genetic diagnosis for Mendelian disorders. Mol Hum Reprod 2011 February 14 (Epub ahead of print).
28. Geraedts JP, De Wert GM. Preimplantation genetic diagnosis. Clin Genet 2009; 76:315-25.
29. The Practice Committee of the American Society for Reproductive Medicine, Practice Committee of the Society for Assisted Reproductive Technology. Revised guidelines for human embryology and andrology laboratories. Fertil Steril 2008; 90:Suppl:S45-S59.
30. Harton G, Braude P, Lashwood A, et al. ESHRE PGD Consortium best practice guidelines for organization of a PGD centre for PGD/preimplantation genetic screening. Hum Reprod 2011;26:14-24.
31. Cooper GM, Coe BP, Girirajan S, et al. A copy number variation morbidity map of developmental delay. Nat Genet 2011; 43:838-46.
32. Committee on Genetics, American College of Obstetricians and Gynecologists. ACOG committee opinion no. 446: array comparative genomic hybridization in prenatal diagnosis. Obstet Gynecol 2009;114:1161-3.
33. Go AT, van Vugt JM, Oudejans CB. Non-invasive aneuploidy detection using free fetal DNA and RNA in maternal plasma: recent progress and future possibilities. Hum Reprod Update 2011;17:372-82.
34. Ehrich M, Deciu C, Zwiefelhofer T, et al. Noninvasive detection of fetal trisomy 21 by sequencing of DNA in maternal blood: a study in a clinical setting. Am J Obstet Gynecol 2011;204(3):205.e1-205.e11.
35. Tsui NB, Akolekar R, Chiu RW, et al. Synergy of PLAC4 RNA concentration and measurement of the RNA single nucleotide polymorphism for the noninvasive prenatal detection of trisomy 21. Clin Chem 2010;56:73-81.
36. Kido S, Sakuragi N, Bronner MP, et al. D21S418E identifies a cAMP-regulated gene located on chromosome 21q22.3 that is expressed in placental syncytiotrophoblast and choriocarcinoma cells. Genomics 1993;17:256-9. (Pubitemid 23205092)
37. Devaney SA, Palomaki GE, Scott JA, Bianchi DW. Noninvasive fetal sex determination using cell-free fetal DNA: a systematic review and meta-analysis. JAMA 2011;306:627-36.
38. Wright CF, Burton H. The use of cellfree fetal nucleic acids in maternal blood for non-invasive prenatal diagnosis. Hum Reprod Update 2009;15:139-51.
39. Lazaros L, Hatzi E, Bouba I, Paraskevaidis E, Georgiou I. Non-invasive prenatal detection of paternal origin Hb Lepore in a male fetus at the 7th week of gestation. Fetal Diagn Ther 2006;21:506-9. (Pubitemid 44804588)
40. Fan HC, Blumenfeld YJ, Chitkara U, Hudgins L, Quake SR. Noninvasive diagnosis of fetal aneuploidy by shotgun sequencing DNA from maternal blood. Proc Natl Acad Sci U S A 2008;105:16266-71.
41. Chiu RWK, Akolekar R, Zheng YWL, et al. Non-invasive prenatal assessment of trisomy 21 by multiplexed maternal plasma DNA sequencing: large scale validity study. BMJ 2011;342:c7401.
42. Peters D, Chu T, Yatsenko SA, et al. Noninvasive prenatal diagnosis of a fetal microdeletion syndrome. N Engl J Med 2011;365:1847-8.
43. Levy PA. An overview of newborn screening. J Dev Behav Pediatr 2010;31: 622-31.
44. Watson MS, Mann MY, Lloyd-Puryear MA, Rinaldo P, Howell RR. Newborn screening: toward a uniform panel and system: executive summary. Genet Med 2006;8:Suppl 1:1S-252S.
45. Green NS, Rinaldo P, Brower A, et al. Committee report: advancing the current recommended panel of conditions for newborn screening. Genet Med 2007;9: 792-6. (Pubitemid 350129414)
46. Lipstein EA, Vorona S, Browning MF, et al. Systematic evidence review of newborn screening and treatment of severe combined immunodeficiency. Pediatrics 2010;125(5):e1226-e1135.
47. Recommended uniform screening panel of the Secretary's advisory committee on heritable disorders in newborns and children. Washington, DC: Department of Health and Human Services, Health Resources and Services Administration, Maternal and Child Health Bureau, 2011 (http://www.hrsa.gov/advisorycommittees/ mchbadvisory/heritabledisorders/recommendedpanel/index.html).
48. Bombard Y, Miller FA, Hayeems RZ, Avard D, Knoppers BM. Reconsidering reproductive benefit through newborn screening: a systematic review of guidelines on preconception, prenatal and newborn screening. Eur J Hum Genet 2010;18: 751-60.
49. Manning M, Hudgins L. Array-based technology and recommendations for utilization in medical genetics practice for detection of chromosomal abnormalities. Genet Med 2010;12:742-5.
50. Hudson KL. Genomics, health care, and society. N Engl J Med 2011;365:1033-41.
51. Anderson SA, Doperak J, Chimes GP. Recommendations for routine sickle cell trait screening for NCAA Division I athletes. PMR 2011;3:168-74.
52. Jostins L, Barrett JC. Genetic risk prediction in complex disease. Hum Mol Genet 2011;20:R182-R188.
53. Borry P, Henneman L, Lakeman P, ten Kate LP, Cornel MC, Howard HC. Preconceptionalgenetic carrier testing and the commercial offer directly-to-consumers. Hum Reprod 2011;26:972-7.
54. Vashlishan Murray AB, Carson MJ, Morris CA, Beckwith J. Illusions of scientific legitimacy: misrepresented science in the direct-to-consumer genetic-testing marketplace. Trends Genet 2010;26:459-61.
55. Foster MW, Mulvihill JJ, Sharp RR. Evaluating the utility of personal genomic information. Genet Med 2009;11:570-4.
56. Summary from the Molecular and Clinical Genetics Panel meeting - March 8-9, 2011. Washington, DC: Department of Health & Human Services. (http://www .fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/ MedicalDevices/MedicalDevicesAdvisory Committee/MolecularandClinical GneticsPanel/UCM246907.pdf).
57. American College of Medical Genetics Board of Directors. ACMG statement on direct-to-consumer genetic testing. Genet Med 2004;6:60.
58. Committee on Genetics, American College of Obstetricians and Gynecologists, Committee on Ethics, American College of Obstetricians and Gynecologists. ACOG committee opinion no. 409: direct-to-consumer marketing of genetic testing. Obstet Gynecol 2008;111:1493-4.
59. Family history, prenatal care, and women's health: development of a family history and genetic screening tool and educational materials for health professionals and the public. Lutherville, MD: National Coalition for Health Professional Education in Genetics, 2010 (http://www.nchpeg.org/index.php? option=com-docman&task =doc-download&grid=59&Itemid=135).
60. Feero WG, Green ED. Genomics education for health care professionals in the 21st century. JAMA 2011;306:989-90.
61. Broussard DL, Sappenfield WB, Fussman C, Kroelinger CD, Grigorescu V. Core state preconception health indicators: a voluntary, multi-state selection process. Matern Child Health J 2011;15:158-68.
62. Ashley EA, Butte AJ, Wheeler MT, et al. Clinical assessment incorporating a personal genome. Lancet 2010;375:1525-35.